BACKGROUND: To review our experience of transmanubrial osteomuscular sparing approach (TMA) for resection of various lesions involving the thoracic inlet and to prove the feasibility and safety of the approach. METHODS: Retrospective review of 58 consecutive cases, from April 2007 to January 2016, with surgical resection of cervico-thoracic lesions via TMA. RESULTS: There were 22 neurogenic tumors, 21 bronchogenic tumors, and 15 other cases in the study. There was no intraoperative or postoperative mortality. Mean postoperative stay was 10.5 days (3-33 days). Mean operation time was 179.0 mins (57-328 mins) and the mean volume of blood loss for bronchogenic tumors was 900 mL, which was similar to non-bronchogenic tumors (474 mL, P=0.103). Moreover, patients with malignant tumors had more intraoperative blood loss than patients with benign diseases did (847 versus 194 mL, P=0.001). R0 resection was achieved in 28 of 33 (84.8%) malignant cases. Tumor size was related to incomplete resection (8.19 vs. 5.72 cm, P=0.023) in malignancy. Five (8.6%) cases were complicated with chylothorax and all occurred in patients with left incision. All of 21 cases (100%) with brachial plexus compression symptom were relieved after surgery and 3 of 4 (75%) cases with Horner's syndrome were ameliorated postoperatively. CONCLUSIONS: TMA can be carried out safely in treating various cervico-thoracic lesions with good resection rate. Left side procedure should be cautious of thoracic duct injury.
BACKGROUND: To review our experience of transmanubrial osteomuscular sparing approach (TMA) for resection of various lesions involving the thoracic inlet and to prove the feasibility and safety of the approach. METHODS: Retrospective review of 58 consecutive cases, from April 2007 to January 2016, with surgical resection of cervico-thoracic lesions via TMA. RESULTS: There were 22 neurogenic tumors, 21 bronchogenic tumors, and 15 other cases in the study. There was no intraoperative or postoperative mortality. Mean postoperative stay was 10.5 days (3-33 days). Mean operation time was 179.0 mins (57-328 mins) and the mean volume of blood loss for bronchogenic tumors was 900 mL, which was similar to non-bronchogenic tumors (474 mL, P=0.103). Moreover, patients with malignant tumors had more intraoperative blood loss than patients with benign diseases did (847 versus 194 mL, P=0.001). R0 resection was achieved in 28 of 33 (84.8%) malignant cases. Tumor size was related to incomplete resection (8.19 vs. 5.72 cm, P=0.023) in malignancy. Five (8.6%) cases were complicated with chylothorax and all occurred in patients with left incision. All of 21 cases (100%) with brachial plexus compression symptom were relieved after surgery and 3 of 4 (75%) cases with Horner's syndrome were ameliorated postoperatively. CONCLUSIONS: TMA can be carried out safely in treating various cervico-thoracic lesions with good resection rate. Left side procedure should be cautious of thoracic duct injury.
Authors: A Marra; W Eberhardt; C Pöttgen; D Theegarten; S Korfee; T Gauler; M Stuschke; G Stamatis Journal: Eur Respir J Date: 2006-09-13 Impact factor: 16.671
Authors: C D Wright; A C Moncure; J A Shepard; E W Wilkins; D J Mathisen; H C Grillo Journal: J Thorac Cardiovasc Surg Date: 1987-07 Impact factor: 5.209
Authors: P G Dartevelle; A R Chapelier; P Macchiarini; B Lenot; J Cerrina; F L Ladurie; F J Parquin; D Lafont Journal: J Thorac Cardiovasc Surg Date: 1993-06 Impact factor: 5.209
Authors: R J Ginsberg; N Martini; M Zaman; J G Armstrong; M S Bains; M E Burt; P M McCormack; V W Rusch; L B Harrison Journal: Ann Thorac Surg Date: 1994-06 Impact factor: 4.330
Authors: K Okubo; H Wada; T Fukuse; H Yokomise; K Inui; O Ike; H Mizuno; M Aoki; S Hitomi Journal: Thorac Cardiovasc Surg Date: 1995-10 Impact factor: 1.827